Medprin announced that the company plans to acquire 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. through the issuance of shares and cash payment, and to raise supporting funds. This transaction is expected not to constitute a major asset reorganization, but it will constitute a related party transaction and will not constitute a reorganization listing. Currently, the company is cooperating with various intermediary institutions to carry out due diligence, auditing, evaluation, and other work, which has not yet been completed. Once the relevant work is completed, the company will hold another board meeting to review the formal plan for this transaction and submit it to the company's shareholders' meeting for consideration
